Invesco RAFI Strategic US ETF (IUS) Chart & Stock Price History → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free IUS Stock Alerts $46.04 +0.03 (+0.07%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestSocial Media Invesco RAFI Strategic US ETF Stock Price Performance5 Day Performance+1.57%1 Month Performance-2.06%3 Month Performance+5.45%6 Month Performance+17.21%Year-To-Date Performance+6.33%1 Year Performance+19.34% Receive IUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco RAFI Strategic US ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! IUS Stock Chart for Wednesday, April, 24, 2024 IUS Chart by TradingView Invesco RAFI Strategic US ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$45.62$46.01+0.85%$46.11$45.71219,395 shs$495.99 million04/22/2024$45.33$45.62+0.64%$45.89$45.3290,710 shs$491.78 million04/19/2024$45.37$45.33-0.09%$45.50$45.16181,101 shs$451.03 million04/18/2024$45.40$45.37-0.07%$45.75$45.3051,543 shs$451.43 million04/17/2024$45.66$45.40-0.57%$45.85$45.3554,036 shs$451.73 million04/16/2024$45.77$45.66-0.24%$45.83$45.54119,091 shs$454.32 million Get the Latest News and Ratings for IUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco RAFI Strategic US ETF and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$46.25$45.77-1.04%$46.64$45.7071,152 shs$432.53 million04/12/2024$46.91$46.25-1.41%$46.76$46.1049,556 shs$437.06 million04/11/2024$46.74$46.91+0.36%$47.02$46.5065,385 shs$443.30 million04/10/2024$47.18$46.74-0.93%$46.95$46.551.39 million shs$441.69 million04/09/2024$47.15$47.18+0.06%$47.30$46.78485,493 shs$441.13 million04/08/2024$47.22$47.15-0.15%$47.30$47.1539,742 shs$440.85 million04/05/2024$46.83$47.22+0.83%$47.36$46.89102,199 shs$329.60 million04/04/2024$47.32$46.83-1.04%$47.66$46.7743,879 shs$326.87 million04/03/2024$47.17$47.32+0.32%$47.39$47.0861,523 shs$330.29 million04/02/2024$47.46$47.17-0.61%$47.17$46.9571,190 shs$329.25 million04/01/2024$47.46$47.46$47.56$47.3661,884 shs$331.27 million03/29/2024$47.46$47.46$47.56$47.3274,094 shs$331.27 million03/28/2024$47.37$47.46+0.19%$47.56$47.3274,094 shs$331.27 million03/27/2024$46.86$47.37+1.09%$47.37$47.01232,855 shs$330.64 million03/26/2024$46.95$46.86-0.19%$47.12$46.84188,982 shs$327.08 million03/25/2024$47.01$46.95-0.13%$47.06$46.91173,447 shs$327.71 million03/22/2024$47.12$47.01-0.23%$47.17$46.9954,852 shs$328.13 million03/21/2024$46.94$47.12+0.38%$47.33$47.1089,288 shs$328.90 million03/20/2024$46.53$46.94+0.88%$46.96$46.4748,816 shs$327.64 million03/19/2024$46.24$46.53+0.63%$46.53$46.1952,436 shs$324.78 million03/18/2024$46.18$46.24+0.13%$46.36$46.1840,633 shs$322.76 million03/15/2024$46.29$46.18-0.24%$46.28$46.0755,320 shs$322.34 million03/14/2024$46.41$46.29-0.26%$46.50$46.1233,068 shs$323.10 million03/13/2024$46.37$46.41+0.09%$46.58$46.3655,547 shs$323.94 million03/12/2024$46.11$46.37+0.56%$46.43$46.1743,523 shs$323.66 million03/11/2024$46.04$46.11+0.15%$46.11$45.8282,527 shs$321.85 million03/08/2024$46.18$46.04-0.30%$46.37$45.9747,018 shs$321.36 million03/07/2024$45.72$46.18+1.01%$46.24$45.9251,989 shs$322.34 million03/06/2024$45.54$45.72+0.40%$45.93$45.6697,836 shs$319.13 million03/05/2024$45.84$45.54-0.65%$45.82$45.3790,393 shs$317.87 million03/04/2024$45.98$45.84-0.30%$45.96$45.82169,729 shs$319.96 million03/01/2024$45.55$45.98+0.94%$46.00$45.64134,687 shs$320.94 million02/29/2024$45.36$45.55+0.42%$45.62$45.37117,764 shs$317.94 million02/28/2024$45.46$45.36-0.22%$45.41$45.2940,101 shs$316.61 millionThe #1 Biotech Stock to Have on Your Radar in 2024… (Ad)Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now!02/27/2024$45.36$45.46+0.22%$45.48$45.3238,517 shs$317.31 million02/26/2024$45.50$45.36-0.31%$45.56$45.3635,450 shs$316.61 million02/23/2024$45.40$45.50+0.22%$45.59$45.4390,866 shs$317.59 million02/22/2024$44.86$45.40+1.20%$45.53$45.0330,495 shs$316.89 million02/21/2024$44.70$44.86+0.36%$44.86$44.5655,281 shs$313.12 million02/20/2024$44.86$44.70-0.36%$44.77$44.60807,185 shs$312.01 million02/19/2024$44.86$44.86$45.13$44.8431,600 shs$313.12 million02/16/2024$45.05$44.86-0.42%$45.13$44.8431,679 shs$313.12 million02/15/2024$44.70$45.05+0.78%$45.11$44.8028,021 shs$314.45 million02/14/2024$44.39$44.70+0.70%$44.72$44.3949,291 shs$312.01 million02/13/2024$45.04$44.39-1.44%$44.54$44.1253,304 shs$309.84 million02/12/2024$44.87$45.04+0.38%$45.21$44.8978,474 shs$314.38 million02/09/2024$44.73$44.87+0.31%$44.87$44.6996,439 shs$313.19 million02/08/2024$44.69$44.73+0.09%$44.75$44.5739,180 shs$312.22 million02/07/2024$44.45$44.69+0.54%$44.72$44.5554,710 shs$311.94 million02/06/2024$44.30$44.45+0.34%$44.47$44.3196,149 shs$310.26 million02/05/2024$44.56$44.30-0.58%$44.46$44.1291,576 shs$309.21 million02/02/2024$44.21$44.56+0.79%$44.72$44.22167,680 shs$308.80 million02/01/2024$43.76$44.21+1.03%$44.24$43.85164,797 shs$306.38 million01/31/2024$44.37$43.76-1.37%$44.21$43.7552,827 shs$303.26 million01/30/2024$44.30$44.37+0.16%$44.42$44.16170,843 shs$307.48 million01/29/2024$44.07$44.30+0.52%$44.30$43.9646,481 shs$307.00 million01/26/2024$44.04$44.07+0.07%$44.15$43.9535,848 shs$296.59 million01/25/2024$43.66$44.04+0.87%$44.04$43.8037,845 shs$296.39 million01/24/2024$43.70$43.66-0.09%$43.96$43.6450,196 shs$293.83 million01/23/2024$43.57$43.70+0.30%$43.73$43.5342,462 shs$292.79 million Related Companies: CFO Stock Chart CDL Stock Chart VFLO Stock Chart FTGS Stock Chart VSDA Stock Chart LRGE Stock Chart NFTY Stock Chart DVAL Stock Chart INDY Stock Chart QQXT Stock Chart Receive IUS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Invesco RAFI Strategic US ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IUS) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco RAFI Strategic US ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.